CH-4051: Phase II started

Chelsea began a 12-week, double-blind, placebo-controlled, international Phase II trial in 250 patients to evaluate once-daily 0.3, 1 or 3 mg oral CH-4051 alone, once-daily 3 mg CH-4051 plus folate, o...